Skip to main navigation
  • About
    • Our Vision
    • Our Approach
    • Our Team
  • Pipeline
    • DARE-BV1
    • OVAPRENE®
    • Sildenafil Cream, 3.6%
  • Partners
  • Consumers
  • Investors
    • Overview
    • Press Releases
    • Presentation, Events & Webcasts
    • Stock Information
      • Stock Quote & Chart
      • Historic Stock Lookup
      • Analyst Coverage
    • Financial Information
      • Financials Overview
      • SEC Filings
      • Annual Reports & Proxies
      • Quarterly Results
    • Corporate Governance
      • Documents & Charters
      • Board of Directors
      • Management
    • Contact
  • Careers
  • Contact Us
    Dare Biosciences
    • Investors
    • Press releases
    • Presentations, Events & Webcasts
    • Stock information
    • Financial Information
    • Corporate governance
    • Contact

    Investors

    Investors

    Corporate Profile

    Daré Bioscience is a clinical-stage biopharmaceutical company committed to the advancement of innovative products for women’s health. The company’s mission is to identify, develop and bring to market a diverse portfolio of differentiated therapies that expand treatment options, improve outcomes and facilitate convenience for women, primarily in the areas of contraception, vaginal health, sexual health, and fertility.

    AST Shareholder Services:
    www.astfinancial.com/contact-us
    (800) 937-5449

    Stock Information

    Change
    Volume
    52 Week High
    52 Week Low
    Jul 5, 2022 9:07 PM EDT

    Data Provided by Refinitiv. Minimum 15 minutes delayed.

    Press Releases

    • Daré Bioscience Announces Closing of Global License Agreement with Organon to Commercialize XACIATO™ (clindamycin phosphate vaginal gel, 2%), FDA-Approved Treatment for Females 12 and Older with Bacterial Vaginosis

      06-30-2022

    • Daré Bioscience Announces Partial Adjournment of Annual Meeting of Stockholders to July 14, 2022

      06-24-2022

    • Daré Bioscience to Participate in the 2022 BIO International Convention

      06-06-2022

    View all press releases »

    Events & Presentations

      More events are coming soon.
    View all events & presentations »
    • Request email alerts |
    • Print this page |
    • Search investor site |

    © 2022 by Daré Bioscience | Daré Bioscience® is a registered trademark of Daré Bioscience, Inc.

    Privacy Policy | Terms of Service | COI Policy |

    Scroll to top